MaxLinear, Inc. Announces Third Quarter 2014 Financial Results

$32.5 Million Third Quarter Revenue Grows 2 Percent Year-Over-Year

CARLSBAD, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE) -- MaxLinear, Inc. (NYSE:MXL), a provider of integrated, radio-frequency (RF) and mixed-signal integrated circuits for broadband communications applications, today announced financial results for the third quarter ended September 30, 2014.

Management Commentary

"On a year-on-year basis, in the third quarter of 2014, our overall revenues grew modestly by approximately 2 percent. We achieved this growth despite the adverse impact of an unanticipated decrease in demand for our Cable DOCSIS3.0 Gateway solutions during the quarter. We believe that our near term growth challenges in Cable are primarily related to a decrease in demand for our higher data rate 16 and 24-channel gateway solutions and HD digital-to-analog converter boxes (DTAs) at certain Cable operators. We do not attribute our Cable weakness to any loss of competitive market position. More significantly, we continue to strengthen our competitive position in Cable with the recent announcement of our industry leading 32-channel Full Spectrum Capture (FSCTM) front-end receiver that supports data speeds in excess of 1 Gigabit per second," commented Kishore Seendripu, Ph.D., Chairman and CEO.

"In the third quarter, in addition to seasonal Terrestrial growth tailwinds, we also benefited in Hybrid TV and set-top boxes as new design-wins transitioned to volume production in the quarter. In Satellite TV, we continue to believe the design-win momentum for Satellite TV gateways and Satellite Outdoor units will yield strong product cycle driven revenue growth in 2015. We remain focused on TAM expansion and revenue diversification initiatives addressing infrastructure markets. Towards this goal, we recently announced our proposed acquisition of Physpeed Corporation, a privately held developer of high-speed physical layer interconnect products addressing enterprise and telecommunications infrastructure market applications."

Generally Accepted Accounting Principles (GAAP) Results

Net revenue for the third quarter of 2014 was $32.5 million, a decrease of 9 percent compared to the second quarter of 2014, and an increase of 2 percent compared to the third quarter of 2013. Gross profit for the third quarter of 2014 was 61.2 percent of revenue, compared to 62.5 percent for the second quarter of 2014, and 62.4 percent for the third quarter of 2013.

Net loss for the third quarter of 2014 was $3.2 million, or $0.09 per share (diluted), compared to net loss of $0.6 million, or $0.02 per share (diluted), for the second quarter of 2014, and net loss of $4.9 million, or $0.14 per share (diluted), for the third quarter of 2013.

Cash flow provided by operations for the third quarter of 2014 totaled $6.4 million, compared to $7.6 million for the second quarter of 2014, and $3.1 million for the third quarter of 2013.

Cash, cash equivalents and investments totaled $93.9 million at September 30, 2014, compared to $91.5 million at June 30, 2014, and $83.0 million at September 30, 2013.

Non-GAAP Results

Non-GAAP gross profit for the third quarter of 2014 was 61.3 percent of revenue, compared to 62.6 percent for the second quarter of 2014, and 62.6 percent for the third quarter of 2013.

Non-GAAP net income for the third quarter of 2014 was $1.7 million, or $0.04 per share (diluted), compared to $5.0 million, or $0.13 per share (diluted), for the second quarter of 2014, and $2.9 million, or $0.08 per share (diluted), for the third quarter of 2013.

Fourth Quarter 2014 Revenue Guidance

We expect revenue in the fourth quarter of 2014 to be between $32 million and $33 million and both GAAP and non-GAAP gross profit percentage to be approximately 60 percent of revenue.

Conference Call Details

MaxLinear will host its third quarter 2014 financial results conference call today, October 30, 2014 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). To access this call, dial US toll free: 1-888-455-2296 / International: 1-719-325-2494 with conference ID: 9632688. A live webcast of the conference call will be accessible from the investor relations section of the MaxLinear website at http://investors.maxlinear.com, and will be archived and available after the call at http://investors.maxlinear.com until November 13, 2014. A replay of the conference call will also be available until November 13, 2014 by dialing US toll free: 1-888-203-1112 / International: 1-719-457-0820 and referencing passcode: 9632688.

Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including our current guidance for fourth quarter 2014 revenue and gross profit percentage); trends and growth opportunities in specific product markets such as cable, terrestrial, and satellite applications; and opportunities associated with new product offerings and our strategy to expand our addressable market, including our proposed acquisition of Physpeed. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. Forward-looking statements are based on management's current, preliminary expectations and are subject to various risks and uncertainties. Risks and uncertainties affecting our business, operating results, and stock price, include, among others, intense competition in our industry; our dependence on a limited number of customers for a substantial portion of our revenues; uncertainties concerning how end user markets for our products will develop, including end user markets for the cable and satellite applications of our products as well as end user markets for products currently in development; potential uncertainties arising from continued consolidation among cable television operators; integration risks associated with our proposed acquisition of Physpeed and any other acquisitions we may pursue; our ability to develop and introduce new and enhanced products on a timely basis and achieve market acceptance of those products, particularly as we seek to expand outside of our historic markets; potential decreases in average selling prices for our products; limited trading volumes; risks relating to intellectual property protection and the prevalence of intellectual property litigation in our industry, including pending litigation against us by a third party with the United States International Trade Commission and in United States District Court in Delaware; our reliance on a limited number of third party manufacturers; and our lack of long-term supply contracts and dependence on limited sources of supply. In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission (SEC), including our most recent Annual Report on Form 10-K and subsequent Form 10-Qs. Additional risks, uncertainties, and other information will be contained in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, which MaxLinear expects to file with the SEC in October 2014.

Use of Non-GAAP Financial Measures

To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP net income (loss), income (loss) from operations, gross profit, and earnings (loss) per share. These supplemental measures exclude the effects of (i) stock-based compensation expense and its related tax effect, if any; (ii) an accrual related to our performance based bonus plan for 2014, which if achieved we intend to settle in stock in 2015; (iii) an accrual related to our performance based bonus plan for 2013, which was settled in stock in May 2014; (iv) impairment of production masks and (v) professional fees and settlement costs related to our previously disclosed IP litigation matters. These non-GAAP measures are not in accordance with and do not serve as an alternative for GAAP. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. These non-GAAP measures should only be viewed in conjunction with corresponding GAAP measures. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.

We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management's incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.

The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:

Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. In addition, we exclude the related tax effect of stock-based compensation expense, if any, from non-GAAP net income.

Bonus payments under our executive and non-executive bonus programs have been excluded from our non-GAAP net income for 2014 and 2013. Bonus payments for the 2013 performance period were settled through the issuance of shares of Class A common stock under our equity incentive plans in May 2014, and we currently expect that any bonus payments under our 2014 programs will also be settled in stock. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income.

Expenses incurred in relation to impairment of production masks reflect costs that were previously capitalized but for which future use is no longer expected.

Expenses incurred in relation to our intellectual property litigation include professional fees incurred and a one-time settlement payment.

Reconciliations of non-GAAP measures disclosed in this press release appear below.

About MaxLinear, Inc.

MaxLinear, Inc. is a provider of integrated, radio-frequency (RF) and mixed-signal integrated circuits for broadband communications applications. MaxLinear is located in Carlsbad, California, and its address on the Internet is www.maxlinear.com.

MXL is MaxLinear's registered trademark. Other trademarks appearing herein are the property of their respective owners.

MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
       
  Three Months Ended
  September 30, June 30, September 30,
  2014 2014 2013
Net revenue $ 32,541 $ 35,592 $ 31,765
Cost of net revenue 12,632 13,346 11,934
Gross profit 19,909 22,246 19,831
Operating expenses:      
Research and development 14,957 13,892 14,569
Selling, general and administrative 8,141 8,688 9,965
Total operating expenses 23,098 22,580 24,534
Loss from operations (3,189) (334) (4,703)
Interest income 61 60 53
Other expense, net (49) (18) (77)
Loss before income taxes (3,177) (292) (4,727)
Provision for income taxes 28 320 155
Net loss $ (3,205) $ (612) $ (4,882)
Net loss per share:      
Basic  $ (0.09)  $ (0.02)  $ (0.14)
Diluted  $ (0.09)  $ (0.02)  $ (0.14)
Shares used to compute net loss per share:      
Basic 36,901 36,093 34,506
Diluted 36,901 36,093 34,506
 
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
     
  Nine Months Ended
  September 30,
  2014 2013
Net revenue  $ 100,634  $ 88,072
Cost of net revenue 38,426 34,233
Gross profit 62,208 53,839
Operating expenses:    
Research and development 41,944 38,395
Selling, general and administrative 24,590 25,136
Total operating expenses 66,534 63,531
Loss from operations (4,326) (9,692)
Interest income 182 170
Interest expense (4)
Other expense, net (79) (194)
Loss before income taxes (4,223) (9,720)
Provision for income taxes 456 366
Net loss  $ (4,679)  $ (10,086)
Net loss per share:    
Basic  $ (0.13)  $ (0.30)
Diluted  $ (0.13)  $ (0.30)
Shares used to compute net loss per share:    
Basic 36,127 33,698
Diluted 36,127 33,698
 
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
       
  Three Months Ended
  September 30, June 30, September 30,
  2014 2014 2013
Operating Activities      
Net loss  $ (3,205)  $ (612)  $ (4,882)
Adjustments to reconcile net loss to cash provided by operating activities:      
Amortization and depreciation 1,322 1,071 874
Amortization of investment premiums, net 168 200 260
Stock-based compensation 4,002 3,685 3,463
Impairment of long-lived assets 8 34
Changes in operating assets and liabilities:      
Accounts receivable 233 690 (1,019)
Inventory 187 1,279 (320)
Prepaid and other assets (60) (300) 186
Accounts payable, accrued expenses and other current liabilities (1,086) 562 (685)
Accrued compensation 1,461 170 2,800
Deferred revenue and deferred profit 2,256 (551) 451
Accrued price protection liability 973 1,132 1,820
Other long-term liabilities 102 224 79
Net cash provided by operating activities 6,361 7,550 3,061
Investing Activities      
Purchases of property and equipment (3,126) (3,196) (811)
Purchases of intangible assets (300)
Purchases of available-for-sale securities (6,693) (11,065) (9,683)
Maturities of available-for-sale securities 6,900 10,800 9,500
Net cash used in investing activities (2,919) (3,461) (1,294)
Financing Activities      
Net proceeds from issuance of common stock 25 1,510 133
Minimum tax withholding paid on behalf of employees for restricted stock units (653) (2,852) (123)
Net cash provided by (used in) financing activities (628) (1,342) 10
Effect of exchange rate changes on cash and cash equivalents (7) 1 5
Increase in cash and cash equivalents 2,807 2,748 1,782
Cash and cash equivalents at beginning of period 31,248 28,500 24,718
Cash and cash equivalents at end of period  $ 34,055  $ 31,248  $ 26,500
 
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
     
  Nine Months Ended
  September 30,
  2014 2013
Operating Activities    
Net loss $ (4,679) $ (10,086)
Adjustments to reconcile net loss to cash provided by operating activities:    
Amortization and depreciation 3,527 2,916
Amortization of investment premiums, net 578 741
Stock-based compensation 11,080 9,591
Deferred income taxes 11
Impairment of long-lived assets 8 1,229
Changes in operating assets and liabilities:    
Accounts receivable (397) (4,316)
Inventory 456 216
Prepaid and other assets (402) (144)
Accounts payable, accrued expenses and other current liabilities 66 (649)
Accrued compensation 3,670 5,001
Deferred revenue and deferred profit 2,234 758
Accrued price protection liability 1,468 4,617
Other long-term liabilities 382 193
Net cash provided by operating activities 18,002 10,067
Investing Activities    
Purchases of property and equipment (7,767) (2,633)
Purchases of intangible assets (955)
Purchases of available-for-sale securities (36,457) (56,800)
Maturities of available-for-sale securities 35,895 55,000
Net cash used in investing activities (8,329) (5,388)
Financing Activities    
Payments on capital leases (2)
Net proceeds from issuance of common stock 1,584 1,246
Minimum tax withholding paid on behalf of employees for restricted stock units (3,641) (1,246)
Net cash used in financing activities (2,057) (2)
Effect of exchange rate changes on cash and cash equivalents (11) 13
Increase in cash and cash equivalents 7,605 4,690
Cash and cash equivalents at beginning of period 26,450 21,810
Cash and cash equivalents at end of period $ 34,055 $ 26,500
 
MAXLINEAR, INC.
UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
       
  September 30, June 30, September 30,
  2014 2014 2013
Assets      
Current assets:      
Cash and cash equivalents  $ 34,055  $ 31,248  $ 26,500
Short-term investments, available-for-sale 47,740 43,875 35,975
Accounts receivable, net 20,455 20,688 18,874
Inventory 9,576 9,763 9,675
Prepaid expenses and other current assets 2,074 1,960 1,622
Total current assets 113,900 107,534 92,646
Property and equipment, net 10,125 9,858 5,890
Long-term investments, available-for-sale 12,122 16,385 20,544
Intangible assets 511 590 829
Other long-term assets 542 596 273
Total assets  $ 137,200  $ 134,963  $ 120,182
Liabilities and stockholders' equity      
Current liabilities  $ 39,691  $ 37,726  $ 34,617
Other long-term liabilities 1,475 1,373 917
Total stockholders' equity 96,034 95,864 84,648
Total liabilities and stockholders' equity  $ 137,200  $ 134,963  $ 120,182
 
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS
(in thousands, except per share data)
       
  Three Months Ended
  September 30, June 30, September 30,
  2014 2014 2013
GAAP net loss  $ (3,205)  $ (612)  $ (4,882)
Stock-based compensation:      
Cost of net revenue 35 32 29
Research and development 2,574 2,384 2,183
Selling, general and administrative 1,393 1,269 1,251
Total stock-based compensation 4,002 3,685 3,463
Share-based bonus plan*:      
Cost of net revenue 13 14
Research and development 6 657 940
Selling, general and administrative 65 564 534
Total share-based bonus plan 71 1,234 1,488
IP litigation costs, net** 876 668 2,826
Non-GAAP net income  $ 1,744  $ 4,975  $ 2,895
Shares used in computing non-GAAP basic net income per share 36,901 36,093 34,506
Shares used in computing GAAP diluted net loss per share 36,901 36,093 34,506
Dilutive common stock equivalents 2,357 2,682 2,136
Shares used in computing non-GAAP diluted net income per share 39,258 38,775 36,642
Non-GAAP basic net income per share  $ 0.05  $ 0.14  $ 0.08
Non-GAAP diluted net income per share  $ 0.04  $ 0.13  $ 0.08
       
* Share-based bonus plan for the three months ended September 30, 2014 and June 30, 2014 relates to an accrual related to our performance based bonus plan for 2014, which will be settled in stock in 2015. Share-based bonus plan for the three months ended September 30, 2013 relates to an accrual related to our performance based bonus plan for 2013, which was settled in stock in May 2014.
** IP litigation costs, net for the three months ended September 30, 2013 includes the one-time payment of $1.25 million in connection with the settlement agreement.
 
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS
(in thousands, except per share data)
     
  Nine Months Ended
  September 30,
  2014 2013
GAAP net loss  $ (4,679)  $ (10,086)
Stock-based compensation:    
Cost of net revenue 96 79
Research and development 7,152 6,095
Selling, general and administrative 3,832 3,417
Total stock-based compensation 11,080 9,591
Share-based bonus plan*:    
Cost of net revenue 22 42
Research and development 1,154 2,455
Selling, general and administrative 1,002 1,176
Total share-based bonus plan 2,178 3,673
Impairment of production masks 1,098
IP litigation costs, net** 1,884 4,899
Non-GAAP net income  $ 10,463  $ 9,175
Shares used in computing non-GAAP basic net income per share 36,127 33,698
Shares used in computing GAAP diluted net loss per share 36,127 33,698
Dilutive common stock equivalents 2,663 1,231
Shares used in computing non-GAAP diluted net income per share 38,790 34,929
Non-GAAP basic net income per share  $ 0.29  $ 0.27
Non-GAAP diluted net income per share  $ 0.27  $ 0.26
     
* Share-based bonus plan for the nine months ended September 30, 2014 relates to an accrual related to our performance based bonus plan for 2014, which will be settled in stock in 2015. Share-based bonus plan for the nine months ended September 30, 2013 relates to an accrual related to our performance based bonus plan for 2013, which was settled in stock in May 2014.
** IP litigation costs, net for the nine months ended September 30, 2013 includes the one-time payment of $1.25 million in connection with the settlement agreement.
 
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
       
  Three Months Ended
  September 30, June 30, September 30,
  2014 2014 2013
GAAP gross profit as a % of revenue 61.2% 62.5% 62.4%
Stock-based compensation:      
Cost of net revenue 0.1% 0.1% 0.1%
Share-based bonus plan:      
Cost of net revenue —% —% 0.1%
Non-GAAP gross profit as a % of revenue 61.3% 62.6% 62.6%
GAAP loss from operations as a % of revenue (9.8)% (0.9)% (14.8)%
Stock-based compensation:      
Cost of net revenue 0.1% 0.1% 0.1%
Research and development 7.9% 6.7% 6.9%
Selling, general and administrative 4.3% 3.6% 3.9%
Share-based bonus plan:      
Cost of net revenue —% —% 0.1%
Research and development —% 1.8% 2.9%
Selling, general and administrative 0.2% 1.6% 1.7%
IP litigation costs, net 2.7% 1.9% 8.9%
Non-GAAP income from operations as a % of revenue 5.4% 14.8% 9.7%
 
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
     
  Nine Months Ended
  September 30,
  2014 2013
GAAP gross profit as a % of revenue 61.8% 61.1%
Stock-based compensation:    
Cost of net revenue 0.1% 0.1%
Share-based bonus plan:    
Cost of net revenue —% 0.1%
Impairment of production masks —% 1.2%
Non-GAAP gross profit as a % of revenue 61.9% 62.5%
GAAP loss from operations as a % of revenue (4.3)% (11.0)%
Stock-based compensation:    
Cost of net revenue 0.1% 0.1%
Research and development 7.1% 6.9%
Selling, general and administrative 3.8% 3.9%
Share-based bonus plan:    
Cost of net revenue —% 0.1%
Research and development 1.1% 2.8%
Selling, general and administrative 1.0% 1.3%
Impairment of production masks —% 1.2%
IP litigation costs, net 1.9% 5.6%
Non-GAAP income from operations as a % of revenue 10.7% 10.9%
CONTACT: MaxLinear, Inc. Investor Relations Contacts:
         Nick Kormeluk
         IR Sense
         Tel: 949-500-0003
         nick@irsense.com

         MaxLinear, Inc. Corporate Contact:
         Adam Spice
         Chief Financial Officer
         Tel: 949-333-0092
Source: MaxLinear, Inc.